 |
FDA Regulations Relating to Good Clinical Practice (GCP) and Clinical Trials
August 8, 2006
Title 21 CFR Information
August 8, 2006
Human Pharmaceutical Products and Veterinary Products Good Manufacturing Practices (GMPs) (21 CFR Parts 210 and 211)
December 6, 2005
21 CFR 58 - Good Laboratory Practice (GLP) for Non-Clinical Lab Studies
April 1, 2005
Current Good Tissue Practice (GTP) for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments
November 24, 2004
Pharmaceutical cGMPs for the 21st Century - A Risk-Based Approach
September 30, 2004
Final Rule: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products
May 25, 2004
Guidance for the Industry - Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans
April 30, 2003
Health Information Portability and Accountability Act (HIPAA)
August 14, 2002
21 CFR Part 11 - Electronic Records; Electronic Signatures; Final Rule
March 20, 1997
|
|
|
|
